RENASCENT III: First in Human Evaluation of the Novel Thin Strut MAGNITUDE Sirolimus-Eluting Ultra-High Molecular Weight MAGNITUDE Bioresorbable Scaffold: 9-Month Imaging and 2-Year Clinical Results

Circ Cardiovasc Interv. 2021 May;14(5):e010013. doi: 10.1161/CIRCINTERVENTIONS.120.010013. Epub 2021 May 18.

¹ Skirball Center for Cardiovascular Research, Cardiovascular Research Foundation, Orangeburg, NY (M.F., J.F.G.).
² Division of Cardiology, Dept of Advanced Biomedical Sciences, University of Naples "Federico II" (M.F., G.E., E.S., M.A.).
³ Department of Interventional Cardiology, Montevergine Clinic, Mercogliano (M.F.).
⁴ Interventional Cardiology Unit, IRCCS San Raffaele Scientific Institute, Milan, Italy (A.C., S.A.K., A.C., A.L.).
⁵ MMSA Clinica Especializada Medellin Columbia (M.M.).
⁶ IRCCS Policlinico San Donato, Milan, Italy (F.B., L.T.).
⁷ Clinical del Norte, Medellin, Colombia (J.A.D.).
⁸ Angiografia de Occidente S.A., Cali, Colombia (C.A.).
⁹ Instituto del Corazon de Bucaramanga, Universidad Industrial de Santander, Colombia (B.V.).
¹⁰ Cardiovascular Research Team, San Carlo Clinic, Milano (B.C.).
¹¹ Cardiovascular Research Foundation, New York (A.M.).

No abstract available

Keywords: angina, unstable; coronary artery disease; myocardial ischemia; polymer; stent.

Publication types